RANDOX TOXICOLOGY LTD

Active Crumlin

Dormant Company

39 employees website.com
Life sciences and medical technology Dormant Company
R

RANDOX TOXICOLOGY LTD

Dormant Company

Founded 27 Jun 2011 Active Crumlin, United Kingdom 39 employees website.com
Life sciences and medical technology Dormant Company
Accounts Submitted 2 Jul 2025 Next due 31 Mar 2026 2 months overdue
Confirmation Submitted 5 Aug 2025 Next due 11 Jul 2026 2 months remaining
Net assets £7M £308K 2024 year on year
Total assets £18M £8M 2024 year on year
Total Liabilities £11M £7M 2024 year on year
Charges 4
4 outstanding

Contact & Details

Contact

Registered Address

55 The Diamond Road Crumlin County Antrim BT29 4QY

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for RANDOX TOXICOLOGY LTD (NI608013), an active life sciences and medical technology company based in Crumlin, United Kingdom. Incorporated 27 Jun 2011. Dormant Company. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2013–2024)

Cash in Bank

£7.50M

Increased by £4.77M (+175%)

Net Assets

£7.04M

Increased by £308.37k (+5%)

Total Liabilities

£10.53M

Increased by £7.46M (+243%)

Turnover

£15.03M

Increased by £335.30k (+2%)

Employees

39

Increased by 6 (+18%)

Debt Ratio

60%

Increased by 29 (+94%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Stephen Peter FitzgeraldDirectorBritishNorthern Ireland7527 Jun 2011Active

Shareholders

Shareholders (1)

Randox Holdings Limited
100.0%

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Stephen Peter Fitzgerald

Northern Irish

Active
Notified 1 May 2016
Residence Northern Ireland
DOB August 1950
Nature of Control
  • Significant Influence Or Control

Randox Holdings Ltd

United Kingdom

Active
Notified 13 Jul 2024
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

RANDOX TOXICOLOGY LTD Current Company

Charges

Charges

4 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
5 Aug 2025Confirmation StatementConfirmation statement made on 27 Jun 2025 with updates
2 Jul 2025OtherNotice of agreement to exemption from audit of accounts for period ending 30/06/24
2 Jul 2025AccountsAnnual accounts made up to 30 Jun 2024
2 Jul 2025AccountsAnnual accounts filed
2 Jul 2025OtherAudit exemption statement of guarantee by parent company for period ending 30/06/24
5 Aug 2025 Confirmation Statement

Confirmation statement made on 27 Jun 2025 with updates

2 Jul 2025 Other

Notice of agreement to exemption from audit of accounts for period ending 30/06/24

2 Jul 2025 Accounts

Annual accounts made up to 30 Jun 2024

2 Jul 2025 Accounts

Annual accounts filed

2 Jul 2025 Other

Audit exemption statement of guarantee by parent company for period ending 30/06/24

Recent Activity

Latest Activity

Confirmation statement made on 27 Jun 2025 with updates

9 months ago on 5 Aug 2025

Notice of agreement to exemption from audit of accounts for period ending 30/06/24

10 months ago on 2 Jul 2025

Annual accounts made up to 30 Jun 2024

10 months ago on 2 Jul 2025

Annual accounts filed

10 months ago on 2 Jul 2025

Audit exemption statement of guarantee by parent company for period ending 30/06/24

10 months ago on 2 Jul 2025